Although a few studies demonstrated the role of HOXD-AS2 in cell cycle regulation and glioma progression [9,10], the molecular mechanism by which HOXD-AS2 modulates the aggressiveness of GBM remain to be fully investigated. Here, HOXD-AS2 is linked to central nervous system cancer.